Ju Zhenlin, Bhardwaj Anjana, Embury Matthew D, Singh Harpreet, Gunaratne Preethi H, Bedrosian Isabelle, Wang Jing
Department of Bioinformatics and Computational Biology, Houston, TX 77030, USA.
Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Cancers (Basel). 2020 Mar 19;12(3):722. doi: 10.3390/cancers12030722.
To characterize molecular changes accompanying the stepwise progression to breast cancer and to identify functional target pathways, we performed miRNA and RNA sequencing using MCF10A cell lines based model system that replicates the multi-step progression involving normal, preneoplastic, ductal carcinoma in situ, and invasive carcinoma cells, where the carcinoma most resemble the basal-like subgroup of human breast cancers. These analyses suggest that 70% of miRNA alterations occurred during the initial progression from normal to a preneoplastic stage. Most of these early changes reflected a global upregulation of miRNAs. This was consistent with a global increase in the miRNA-processing enzyme DICER, which was upregulated as a direct result of loss of miRNA let-7b-5p. Several oncogenic and tumor suppressor pathways were also found to change early, prior to histologic stigmata of cancer. Our finding that most genomic changes in the progression to basal-like breast cancer occurred in the earliest stages of histologic progression has implications for breast cancer prevention and selection of appropriate control tissues in molecular studies. Furthermore, in support of a functional significance of let-7b-5p loss, we found its low levels to predict poor disease-free survival and overall survival in breast cancer patients.
为了描述伴随乳腺癌逐步进展的分子变化并确定功能性靶标通路,我们使用基于MCF10A细胞系的模型系统进行了miRNA和RNA测序,该系统复制了涉及正常、癌前、原位导管癌和浸润性癌细胞的多步骤进展过程,其中癌最类似于人类乳腺癌的基底样亚组。这些分析表明,70%的miRNA改变发生在从正常到癌前阶段的初始进展过程中。这些早期变化大多反映了miRNA的整体上调。这与miRNA加工酶DICER的整体增加一致,DICER的上调是miRNA let-7b-5p缺失的直接结果。还发现一些致癌和肿瘤抑制通路在癌症的组织学特征出现之前就发生了早期变化。我们的发现表明,基底样乳腺癌进展过程中的大多数基因组变化发生在组织学进展的最早阶段,这对乳腺癌预防以及分子研究中合适对照组织的选择具有重要意义。此外,为了支持let-7b-5p缺失的功能意义,我们发现其低水平可预测乳腺癌患者较差的无病生存期和总生存期。